HedgePath Pharmaceuticals (HPPI) SEC Filings & 10K Form $0.08 -0.01 (-11.11%) (As of 11/14/2024 ET) Add Compare Share Share SEC Filings Stock AnalysisChartFinancialsSEC Filings Recent HedgePath Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView11/12/20245:27 AMHedgePath Pharmaceuticals (Filer)Inhibitor Therapeutics, Inc. (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/06/20248:30 AMHedgePath Pharmaceuticals (Filer)Inhibitor Therapeutics, Inc. (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/16/202412:34 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)Jerman Michael Allen (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)OSMAN RONALD E (Reporting)Ronald E Osman Irrevocable Trust III (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)SEARS SAMUEL P JR (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)MCNULTY JAMES A (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/202412:34 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)Yanez Michelle (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20248:00 AMHedgePath Pharmaceuticals (Filer)Inhibitor Therapeutics, Inc. (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 12/14/20235:02 AMHedgePath Pharmaceuticals (Filer)Inhibitor Therapeutics, Inc. (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Luna Innovations SEC Filings Inotiv SEC Filings OneMedNet SEC Filings bioAffinity Technologies SEC Filings AIkido Pharma SEC Filings FOXO Technologies SEC Filings iSpecimen SEC Filings Data Knights Acquisition SEC Filings U.S. Stem Cell SEC Filings IQVIA SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:HPPI) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HedgePath Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share HedgePath Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
